siRNA-mediated inhibition of E2A-PBX1 reduces EB-1 and Wnt16b expression in 697 pre-B leukemia cells.
Schwaller
Juerg
J
University Hospital Basel, Department of Research, Basel, Switzerland. j.schwaller@unibas.ch
D017209:Apoptosis; D005786:Gene Expression Regulation; D018398:Homeodomain Proteins / Q000037:antagonists & inhibitors / Q000235:genetics*; D006801:Humans; D007938:Leukemia / Q000235:genetics / Q000473:pathology; D015514:Oncogene Proteins, Fusion / Q000037:antagonists & inhibitors / Q000235:genetics*; D034741:RNA, Small Interfering / Q000235:genetics*; D014157:Transcription Factors / Q000378:metabolism; D014158:Transcription, Genetic
D018398:Homeodomain Proteins; D015514:Oncogene Proteins, Fusion; D034741:RNA, Small Interfering; D014157:Transcription Factors; C089847:E2A-Pbx1 fusion protein